Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Latest News Releases
Updates every hour. Last Updated: 3-Nov-2026 08:16 ET (3-Nov-2026 13:16 GMT/UTC)
How deep sleep shapes mental resilience to stressful situations
Society for NeurosciencePeer-Reviewed Publication
- Journal
- JNeurosci
- Funder
- Howard Hughes Medical Institute
AI could make holiday planning easier for overwhelmed travellers
University of SurreyPeer-Reviewed Publication
- Journal
- Journal of Travel Research
Nature Biotechnology | Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks
InSilico MedicinePeer-Reviewed Publication
First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment).
First Universal Consensus Across Six Independently-Developed Proteomic Aging Clocks: Analyzing 12-week longitudinal Olink proteomic data from 42 IPF patients, six aging clock models (including ProtAge, OrganAge, and PAC) independently developed by the leading groups from Harvard, Oxford, PKU, and Insilico, unanimously indicated that rentosertib reversed predicted biological age.
First Scalable Blueprint for Dual-Purpose Clinical Trials: The study is the first demonstration of a novel drug for a novel target discovered using aging research purposed to the age-related disease with aging biomarkers applied in a context of a clinical study. It establishes a standardized framework for embedding geroscience endpoints into standard disease trials, aligned with FDA Biomarker/BEST guidelines for dual-purpose aging and disease therapeutics.
- Journal
- Nature Biotechnology
Laser-carved artificial skin feels everything from a falling feather to a heavy-duty truck tire
International Journal of Extreme ManufacturingPeer-Reviewed Publication
In International Journal of Extreme Manufacturing, researchers fired ultrafast laser bursts at titanium foil and carved dual-scale microscopic textures in a single manufacturing step to create an artificial skin that handles both extremes.
- Journal
- International Journal of Extreme Manufacturing
Optimizing tomato plant growth with microbes
Kyoto UniversityPeer-Reviewed Publication
Kyoto, Japan -- Plants are home to a diverse array of microorganisms that support their growth and help them adapt to environmental stress -- of which there has been an abundance of late. High temperatures and drought caused by human-induced climate change have led to reduced crop yields and the use of biofertilizers such as rhizosphere microorganisms, which help plants absorb nutrients and increase their resistance to disease and stresses. Yet single microorganisms have difficulties sustaining themselves in crops and remaining functional in the fluctuating environment of an agricultural field. This is where microbial communities can help.
A recent approach involves creating defined microbial communities -- DMCs -- by combining multiple microorganisms, which in turn influence each other and can thereby strengthen their resilience. However, the composition and function of such a community changes depending on plant-specialized metabolites and environmental conditions, rendering these rather impractical to use in conventional trial-and-error experiments aiming to find optimal microbial communities from amongst a vast number of combinations.
This motivated a team of researchers from Kyoto University, with help from colleagues at Tohoku University and RIKEN, to integrate microorganism data and establish a rational, predictable method for designing DMCs. The team chose the humble tomato as their plant subject.
- Journal
- The ISME Journal
- Funder
- Japan Science and Technology Agency
Weekly丨Insilico leadership to present at major global conferences
InSilico MedicineMeeting Announcement
September 7–9 | Dubai
Dr. Alex Aliper, Co-Founder and President of Insilico Medicine, has been invited to attend the AIM Congress 2026 in Dubai from September 7 to 9.September 8 | Macau, China
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend and speak at the Fortune Leaders Forum in Macao on September 8.September 8–10 | Paris
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to speak at the Nature conference: Redefining Healthcare in the Age of AI in Paris on September 8 at 16:30.September 8–11 | Oxford
Insilico Medicine has been invited to attend the 75th BSRA Annual Scientific Meeting (2026) at the University of Oxford from September 8 to 11.